Tavolinejad Hamed, Boczar Kevin E, Spronck Bart, Maynard Hannah, Bertoni Alain G, Shah Sanjiv J, Chirinos Julio A
Division of Cardiovascular Medicine, Hospital of the University of Pennsylvania, Philadelphia (H.T., H.M., J.A.C.).
University of Pennsylvania Perelman School of Medicine, Philadelphia (H.T., H.M., J.A.C.).
Hypertension. 2025 Jun;82(6):1081-1094. doi: 10.1161/HYPERTENSIONAHA.124.23970. Epub 2025 Mar 7.
The cardio-ankle vascular index (CAVI) and heart-thigh β index (htβ) assess arterial stiffness by correcting pulse wave velocity for blood pressure to achieve less dependency on blood pressure variations. Normative data for these markers among US communities are lacking. We aimed to assess the determinants and normative values of CAVI and htβ.
MESA (Multi-Ethnic Study of Atherosclerosis) participants with CAVI and htβ measurements were included (N=2950). A subgroup selected to define normative values included only participants without previous cardiovascular disease, diabetes, smoking, antihypertensive use, and with blood pressure <140/90 mm Hg, body mass index <35 kg/m, and creatinine <1.5 mg/dL. Associations were assessed by multivariable linear regressions. All continuous variables were standardized.
Among 2950 participants (mean age, 73.6 years; 47.2% male), older age (β for CAVI=0.39, <0.001 and htβ=0.41, <0.001), and male sex (β for CAVI=0.30, <0.001 and htβ=0.11, <0.001) were associated with higher arterial indices. Participants with higher blood pressure, height, and diabetes exhibited higher CAVI and htβ. A higher waist circumference was associated with lower CAVI and htβ. Among the normative value subgroup (N=676), the mean CAVI was 8.7 (2 Z score range, 6.5-11.2), and the mean htβ was 8.9 (2 Z score range, 4.3-13.6). Among participants without cardiovascular disease, higher CAVI and htβ were associated with higher predicted 10-year cardiovascular risk estimated by pooled cohort equations (per SD of CAVI=3.6%, <0.001 and htβ=3.3%, <0.001).
We report determinants and normative values of CAVI and htβ in a multiethnic community-based US population. Future studies should focus on the prognostic utility of CAVI and htβ.
心踝血管指数(CAVI)和心股β指数(htβ)通过校正脉波速度以消除血压的影响来评估动脉僵硬度,从而降低对血压变化的依赖性。美国人群中这些指标的正常参考数据尚缺乏。我们旨在评估CAVI和htβ的决定因素及正常参考值。
纳入有CAVI和htβ测量值的动脉粥样硬化多民族研究(MESA)参与者(N = 2950)。一个用于定义正常参考值的亚组仅包括既往无心血管疾病、糖尿病、吸烟史,未使用抗高血压药物,且血压<140/90 mmHg、体重指数<35 kg/m²、肌酐<1.5 mg/dL的参与者。通过多变量线性回归评估相关性。所有连续变量均进行了标准化处理。
在2950名参与者中(平均年龄73.6岁;男性占47.2%),年龄较大(CAVI的β值=0.39,P<0.001;htβ的β值=0.41,P<0.001)以及男性(CAVI的β值=0.30,P<0.001;htβ的β值=0.11,P<0.001)与较高的动脉指数相关。血压、身高较高以及患有糖尿病的参与者CAVI和htβ较高。腰围较大与较低的CAVI和htβ相关。在正常参考值亚组(N = 676)中,CAVI的平均值为8.7(2个Z分数范围为6.5 - 11.2),htβ的平均值为8.9(2个Z分数范围为4.3 - 13.6)。在无心血管疾病的参与者中,较高的CAVI和htβ与根据合并队列方程估计的较高的10年心血管风险相关(CAVI每增加1个标准差为3.6%,P<0.001;htβ每增加1个标准差为3.3%,P<0.001)。
我们报告了美国多民族社区人群中CAVI和htβ的决定因素及正常参考值。未来的研究应关注CAVI和htβ的预后效用。